<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36670122</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>20</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Integrative genetic analysis illuminates ALS heritability and identifies risk genes.</ArticleTitle><Pagination><StartPage>342</StartPage><MedlinePgn>342</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">342</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-022-35724-1</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) has substantial heritability, in part shared with fronto-temporal dementia (FTD). We show that ALS heritability is enriched in splicing variants and in binding sites of 6 RNA-binding proteins including TDP-43 and FUS. A transcriptome wide association study (TWAS) identified 6 loci associated with ALS, including in NUP50 encoding for the nucleopore basket protein NUP50. Independently, rare variants in NUP50 were associated with ALS risk (P&#x2009;=&#x2009;3.71.10<sup>-03</sup>; odds ratio = 3.29; 95%CI, 1.37 to 7.87) in a cohort of 9,390 ALS/FTD patients and 4,594 controls. Cells from one patient carrying a NUP50 frameshift mutation displayed a decreased level of NUP50. Loss of NUP50 leads to death of cultured neurons, and motor defects in Drosophila and zebrafish. Thus, our study identifies alterations in splicing in neurons as critical in ALS and provides genetic evidence linking nuclear pore defects to ALS.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Megat</LastName><ForeName>Salim</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-2186-6770</Identifier><AffiliationInfo><Affiliation>Universit&#xe9; de Strasbourg, Inserm, M&#xe9;canismes centraux et p&#xe9;riph&#xe9;riques de la neurod&#xe9;g&#xe9;n&#xe9;rescence, UMR-S1118, Centre de Recherches en Biom&#xe9;decine, Strasbourg, France. salim.megat@inserm.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mora</LastName><ForeName>Natalia</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-2183-7753</Identifier><AffiliationInfo><Affiliation>Department of Molecular Neurobiology, Donders Institute for Brain, Cognition and Behaviour and Faculty of Science, Radboud University, Nijmegen, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanogo</LastName><ForeName>Jason</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Strasbourg, Inserm, M&#xe9;canismes centraux et p&#xe9;riph&#xe9;riques de la neurod&#xe9;g&#xe9;n&#xe9;rescence, UMR-S1118, Centre de Recherches en Biom&#xe9;decine, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roman</LastName><ForeName>Olga</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Strasbourg, Inserm, M&#xe9;canismes centraux et p&#xe9;riph&#xe9;riques de la neurod&#xe9;g&#xe9;n&#xe9;rescence, UMR-S1118, Centre de Recherches en Biom&#xe9;decine, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Catanese</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-8266-4913</Identifier><AffiliationInfo><Affiliation>Institute of Anatomy and Cell Biology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE) Ulm, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alami</LastName><ForeName>Najwa Ouali</ForeName><Initials>NO</Initials><AffiliationInfo><Affiliation>Clinical Neuroanatomy, Department of Neurology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freischmidt</LastName><ForeName>Axel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE) Ulm, Ulm, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mingaj</LastName><ForeName>Xhuljana</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Laboratory of Translational Research for Neurological Disorders, Imagine Institute, Universit&#xe9; de Paris, INSERM UMR 1163, 75015, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Calbiac</LastName><ForeName>Hortense</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Laboratory of Translational Research for Neurological Disorders, Imagine Institute, Universit&#xe9; de Paris, INSERM UMR 1163, 75015, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muratet</LastName><ForeName>Fran&#xe7;ois</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, H&#xf4;pital de la Piti&#xe9; Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dirrig-Grosch</LastName><ForeName>Sylvie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Strasbourg, Inserm, M&#xe9;canismes centraux et p&#xe9;riph&#xe9;riques de la neurod&#xe9;g&#xe9;n&#xe9;rescence, UMR-S1118, Centre de Recherches en Biom&#xe9;decine, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dieterle</LastName><ForeName>St&#xe9;phane</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Strasbourg, Inserm, M&#xe9;canismes centraux et p&#xe9;riph&#xe9;riques de la neurod&#xe9;g&#xe9;n&#xe9;rescence, UMR-S1118, Centre de Recherches en Biom&#xe9;decine, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Bakel</LastName><ForeName>Nick</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Molecular Neurobiology, Donders Institute for Brain, Cognition and Behaviour and Faculty of Science, Radboud University, Nijmegen, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xfc;ller</LastName><ForeName>Kathrin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE) Ulm, Ulm, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Human Genetics, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sieverding</LastName><ForeName>Kirsten</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE) Ulm, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weishaupt</LastName><ForeName>Jochen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division for Neurodegenerative Diseases, Neurology Department, University Medicine Mannheim, Heidelberg University, Mannheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andersen</LastName><ForeName>Peter Munch</ForeName><Initials>PM</Initials><Identifier Source="ORCID">0000-0003-0094-5429</Identifier><AffiliationInfo><Affiliation>Department of Clinical Science, Neurosciences, Umea University, Umea, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weber</LastName><ForeName>Markus</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5538-9274</Identifier><AffiliationInfo><Affiliation>Neuromuscular Disease Unit/ALS Clinic, Kantonsspital St. Gallen, St. Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neuwirth</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-1874-8872</Identifier><AffiliationInfo><Affiliation>Neuromuscular Disease Unit/ALS Clinic, Kantonsspital St. Gallen, St. Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Margelisch</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Pathology, Kanstonsspital St. Gallen, St. Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sommacal</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute for Pathology, Kanstonsspital St. Gallen, St. Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Eijk</LastName><ForeName>Kristel R</ForeName><Initials>KR</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Medical Center Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Veldink</LastName><ForeName>Jan H</ForeName><Initials>JH</Initials><Identifier Source="ORCID">0000-0001-5572-9657</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University Medical Center Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Project Mine Als Sequencing Consortium</CollectiveName></Author><Author ValidYN="Y"><LastName>Lautrette</LastName><ForeName>G&#xe9;raldine</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Service de Neurologie, Centre de R&#xe9;f&#xe9;rence SLA et autres maladies du neurone moteur, CHU Dupuytren 1, Limoges, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Couratier</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Service de Neurologie, Centre de R&#xe9;f&#xe9;rence SLA et autres maladies du neurone moteur, CHU Dupuytren 1, Limoges, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camuzat</LastName><ForeName>Agn&#xe8;s</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, H&#xf4;pital de la Piti&#xe9; Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le Ber</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, H&#xf4;pital de la Piti&#xe9; Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grassano</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>ALS Center "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chio</LastName><ForeName>Adriano</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>ALS Center "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boeckers</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-1486-8535</Identifier><AffiliationInfo><Affiliation>Institute of Anatomy and Cell Biology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE) Ulm, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ludolph</LastName><ForeName>Albert C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE) Ulm, Ulm, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roselli</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>German Center for Neurodegenerative Diseases (DZNE) Ulm, Ulm, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yilmazer-Hanke</LastName><ForeName>Deniz</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Clinical Neuroanatomy, Department of Neurology, Ulm University, Ulm, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Millecamps</LastName><ForeName>St&#xe9;phanie</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-0745-6735</Identifier><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, H&#xf4;pital de la Piti&#xe9; Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Kabashi</LastName><ForeName>Edor</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Laboratory of Translational Research for Neurological Disorders, Imagine Institute, Universit&#xe9; de Paris, INSERM UMR 1163, 75015, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Storkebaum</LastName><ForeName>Erik</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9519-5642</Identifier><AffiliationInfo><Affiliation>Department of Molecular Neurobiology, Donders Institute for Brain, Cognition and Behaviour and Faculty of Science, Radboud University, Nijmegen, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Sellier</LastName><ForeName>Chantal</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Strasbourg, Inserm, M&#xe9;canismes centraux et p&#xe9;riph&#xe9;riques de la neurod&#xe9;g&#xe9;n&#xe9;rescence, UMR-S1118, Centre de Recherches en Biom&#xe9;decine, Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Dupuis</LastName><ForeName>Luc</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-0902-5824</Identifier><AffiliationInfo><Affiliation>Universit&#xe9; de Strasbourg, Inserm, M&#xe9;canismes centraux et p&#xe9;riph&#xe9;riques de la neurod&#xe9;g&#xe9;n&#xe9;rescence, UMR-S1118, Centre de Recherches en Biom&#xe9;decine, Strasbourg, France. ldupuis@unistra.fr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034702">RNA-Binding Protein FUS</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015027" MajorTopicYN="N">Zebrafish</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D034702" MajorTopicYN="N">RNA-Binding Protein FUS</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>J.H.V. reports having sponsored research agreements with Biogen. L.D. reports having sponsored research agreements with Inflectis Bioscience and Cytokinetics. All other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>20</Day><Hour>23</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36670122</ArticleId><ArticleId IdType="pmc">PMC9860017</ArticleId><ArticleId IdType="doi">10.1038/s41467-022-35724-1</ArticleId><ArticleId IdType="pii">10.1038/s41467-022-35724-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gregory, J. M., Fagegaltier, D., Phatnani, H. &amp; Harms, M. B. Genetics of amyotrophic lateral sclerosis. Curr. Genet. Med. Rep.8, 121&#x2013;131 (2020).</Citation></Reference><Reference><Citation>Brown RH, Jr., Al-Chalabi A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es MA, et al. Amyotrophic lateral sclerosis. Lancet. 2017;390:2084&#x2013;2098. doi: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, et al. An estimate of amyotrophic lateral sclerosis heritability using twin data. J. Neurol. Neurosurg. Psychiatry. 2010;81:1324&#x2013;1326. doi: 10.1136/jnnp.2010.207464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.207464</ArticleId><ArticleId IdType="pmc">PMC2988617</ArticleId><ArticleId IdType="pubmed">20861059</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan M, Heverin M, McLaughlin RL, Hardiman O. Lifetime risk and heritability of amyotrophic lateral sclerosis. JAMA Neurol. 2019;76:1367&#x2013;1374. doi: 10.1001/jamaneurol.2019.2044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2019.2044</ArticleId><ArticleId IdType="pmc">PMC6646974</ArticleId><ArticleId IdType="pubmed">31329211</ArticleId></ArticleIdList></Reference><Reference><Citation>Trabjerg BB, et al. ALS in Danish registries: heritability and links to psychiatric and cardiovascular disorders. Neurol. Genet. 2020;6:e398. doi: 10.1212/NXG.0000000000000398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXG.0000000000000398</ArticleId><ArticleId IdType="pmc">PMC7073454</ArticleId><ArticleId IdType="pubmed">32211514</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rheenen W, et al. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat. Genet. 2016;48:1043&#x2013;1048. doi: 10.1038/ng.3622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3622</ArticleId><ArticleId IdType="pmc">PMC5556360</ArticleId><ArticleId IdType="pubmed">27455348</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rheenen W, et al. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology. Nat. Genet. 2021;53:1636&#x2013;1648. doi: 10.1038/s41588-021-00973-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-00973-1</ArticleId><ArticleId IdType="pmc">PMC8648564</ArticleId><ArticleId IdType="pubmed">34873335</ArticleId></ArticleIdList></Reference><Reference><Citation>Wingo AP, et al. Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer&#x2019;s disease pathogenesis. Nat. Genet. 2021;53:143&#x2013;146. doi: 10.1038/s41588-020-00773-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-020-00773-z</ArticleId><ArticleId IdType="pmc">PMC8130821</ArticleId><ArticleId IdType="pubmed">33510477</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YI, Wong G, Humphrey J, Raj T. Prioritizing Parkinson&#x2019;s disease genes using population-scale transcriptomic data. Nat. Commun. 2019;10:994. doi: 10.1038/s41467-019-08912-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-08912-9</ArticleId><ArticleId IdType="pmc">PMC6397174</ArticleId><ArticleId IdType="pubmed">30824768</ArticleId></ArticleIdList></Reference><Reference><Citation>Kia DA, et al. Identification of candidate Parkinson disease genes by integrating genome-wide association study, expression, and epigenetic data sets. JAMA Neurol. 2021;78:464&#x2013;472. doi: 10.1001/jamaneurol.2020.5257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.5257</ArticleId><ArticleId IdType="pmc">PMC7851759</ArticleId><ArticleId IdType="pubmed">33523105</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling JP, Pletnikova O, Troncoso JC, Wong PC. TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD. Science. 2015;349:650&#x2013;655. doi: 10.1126/science.aab0983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aab0983</ArticleId><ArticleId IdType="pmc">PMC4825810</ArticleId><ArticleId IdType="pubmed">26250685</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown AL, et al. TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A. Nature. 2022;603:131&#x2013;137. doi: 10.1038/s41586-022-04436-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04436-3</ArticleId><ArticleId IdType="pmc">PMC8891020</ArticleId><ArticleId IdType="pubmed">35197628</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma XR, et al. TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13A. Nature. 2022;603:124&#x2013;130. doi: 10.1038/s41586-022-04424-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04424-7</ArticleId><ArticleId IdType="pmc">PMC8891019</ArticleId><ArticleId IdType="pubmed">35197626</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, et al. GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature. 2015;525:129&#x2013;133. doi: 10.1038/nature14974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14974</ArticleId><ArticleId IdType="pmc">PMC4631399</ArticleId><ArticleId IdType="pubmed">26308899</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K, et al. The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature. 2015;525:56&#x2013;61. doi: 10.1038/nature14973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14973</ArticleId><ArticleId IdType="pmc">PMC4800742</ArticleId><ArticleId IdType="pubmed">26308891</ArticleId></ArticleIdList></Reference><Reference><Citation>Jovi&#x10d;i&#x107; A, et al. Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS. Nat. Neurosci. 2015;18:1226&#x2013;1229. doi: 10.1038/nn.4085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4085</ArticleId><ArticleId IdType="pmc">PMC4552077</ArticleId><ArticleId IdType="pubmed">26308983</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S, et al. Drosophila screen connects nuclear transport genes to DPR pathology in c9ALS/FTD. Sci. Rep. 2016;6:20877. doi: 10.1038/srep20877.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep20877</ArticleId><ArticleId IdType="pmc">PMC4751451</ArticleId><ArticleId IdType="pubmed">26869068</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook, C. N. et al. C9orf72 poly(GR) aggregation induces TDP-43 proteinopathy. Sci. Transl. Med.12, eabb3774 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7989020</ArticleId><ArticleId IdType="pubmed">32878979</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne, A. N. et al. Nuclear accumulation of CHMP7 initiates nuclear pore complex injury and subsequent TDP-43 dysfunction in sporadic and familial ALS. Sci. Transl. Med.13, eabe1923 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9022198</ArticleId><ArticleId IdType="pubmed">34321318</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou CC, et al. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD. Nat. Neurosci. 2018;21:228&#x2013;239. doi: 10.1038/s41593-017-0047-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-017-0047-3</ArticleId><ArticleId IdType="pmc">PMC5800968</ArticleId><ArticleId IdType="pubmed">29311743</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YC, et al. Interactions between ALS-linked FUS and nucleoporins are associated with defects in the nucleocytoplasmic transport pathway. Nat. Neurosci. 2021;24:1077&#x2013;1088. doi: 10.1038/s41593-021-00859-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-021-00859-9</ArticleId><ArticleId IdType="pmc">PMC8832378</ArticleId><ArticleId IdType="pubmed">34059832</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaneb HM, et al. Deleterious mutations in the essential mRNA metabolism factor, hGle1, in amyotrophic lateral sclerosis. Hum. Mol. Genet. 2015;24:1363&#x2013;1373. doi: 10.1093/hmg/ddu545.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu545</ArticleId><ArticleId IdType="pmc">PMC4321443</ArticleId><ArticleId IdType="pubmed">25343993</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulik-Sullivan BK, et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 2015;47:291&#x2013;295. doi: 10.1038/ng.3211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3211</ArticleId><ArticleId IdType="pmc">PMC4495769</ArticleId><ArticleId IdType="pubmed">25642630</ArticleId></ArticleIdList></Reference><Reference><Citation>Corces MR, et al. Single-cell epigenomic analyses implicate candidate causal variants at inherited risk loci for Alzheimer&#x2019;s and Parkinson&#x2019;s diseases. Nat. Genet. 2020;52:1158&#x2013;1168. doi: 10.1038/s41588-020-00721-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-020-00721-x</ArticleId><ArticleId IdType="pmc">PMC7606627</ArticleId><ArticleId IdType="pubmed">33106633</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, et al. Genetic drivers of epigenetic and transcriptional variation in human immune cells. Cell. 2016;167:1398&#x2013;1414 e1324. doi: 10.1016/j.cell.2016.10.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.10.026</ArticleId><ArticleId IdType="pmc">PMC5119954</ArticleId><ArticleId IdType="pubmed">27863251</ArticleId></ArticleIdList></Reference><Reference><Citation>Hormozdiari F, Kostem E, Kang EY, Pasaniuc B, Eskin E. Identifying causal variants at loci with multiple signals of association. Genetics. 2014;198:497&#x2013;508. doi: 10.1534/genetics.114.167908.</Citation><ArticleIdList><ArticleId IdType="doi">10.1534/genetics.114.167908</ArticleId><ArticleId IdType="pmc">PMC4196608</ArticleId><ArticleId IdType="pubmed">25104515</ArticleId></ArticleIdList></Reference><Reference><Citation>Lek M, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285&#x2013;291. doi: 10.1038/nature19057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature19057</ArticleId><ArticleId IdType="pmc">PMC5018207</ArticleId><ArticleId IdType="pubmed">27535533</ArticleId></ArticleIdList></Reference><Reference><Citation>Marzi SJ, et al. A histone acetylome-wide association study of Alzheimer&#x2019;s disease identifies disease-associated H3K27ac differences in the entorhinal cortex. Nat. Neurosci. 2018;21:1618&#x2013;1627. doi: 10.1038/s41593-018-0253-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0253-7</ArticleId><ArticleId IdType="pubmed">30349106</ArticleId></ArticleIdList></Reference><Reference><Citation>Park CY, et al. Genome-wide landscape of RNA-binding protein target site dysregulation reveals a major impact on psychiatric disorder risk. Nat. Genet. 2021;53:166&#x2013;173. doi: 10.1038/s41588-020-00761-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-020-00761-3</ArticleId><ArticleId IdType="pmc">PMC7886016</ArticleId><ArticleId IdType="pubmed">33462483</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Nostrand EL, et al. A large-scale binding and functional map of human RNA-binding proteins. Nature. 2020;583:711&#x2013;719. doi: 10.1038/s41586-020-2077-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2077-3</ArticleId><ArticleId IdType="pmc">PMC7410833</ArticleId><ArticleId IdType="pubmed">32728246</ArticleId></ArticleIdList></Reference><Reference><Citation>Gusev A, et al. Integrative approaches for large-scale transcriptome-wide association studies. Nat. Genet. 2016;48:245&#x2013;252. doi: 10.1038/ng.3506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3506</ArticleId><ArticleId IdType="pmc">PMC4767558</ArticleId><ArticleId IdType="pubmed">26854917</ArticleId></ArticleIdList></Reference><Reference><Citation>Consortium GT. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science. 2020;369:1318&#x2013;1330. doi: 10.1126/science.aaz1776.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaz1776</ArticleId><ArticleId IdType="pmc">PMC7737656</ArticleId><ArticleId IdType="pubmed">32913098</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas A, et al. Genome-wide analyses Identify KIF5A as a Novel ALS Gene. Neuron. 2018;97:1268&#x2013;1283 e1266. doi: 10.1016/j.neuron.2018.02.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.02.027</ArticleId><ArticleId IdType="pmc">PMC5867896</ArticleId><ArticleId IdType="pubmed">29566793</ArticleId></ArticleIdList></Reference><Reference><Citation>Grassano M, et al. Systematic evaluation of genetic mutations in ALS: a population-based study. J. Neurol. Neurosurg. Psychiatry. 2022;93:1190&#x2013;1193.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9606529</ArticleId><ArticleId IdType="pubmed">35896380</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancuso N, et al. Probabilistic fine-mapping of transcriptome-wide association studies. Nat. Genet. 2019;51:675&#x2013;682. doi: 10.1038/s41588-019-0367-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-019-0367-1</ArticleId><ArticleId IdType="pmc">PMC6619422</ArticleId><ArticleId IdType="pubmed">30926970</ArticleId></ArticleIdList></Reference><Reference><Citation>Teyssou E, et al. Genetic screening of ANXA11 revealed novel mutations linked to amyotrophic lateral sclerosis. Neurobiol. Aging. 2021;99:102 e111&#x2013;102 e120. doi: 10.1016/j.neurobiolaging.2020.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2020.10.015</ArticleId><ArticleId IdType="pubmed">33218681</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyne AN, et al. G4C2 repeat RNA initiates a POM121-mediated reduction in specific nucleoporins in C9orf72 ALS/FTD. Neuron. 2020;107:1124&#x2013;1140 e1111. doi: 10.1016/j.neuron.2020.06.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.06.027</ArticleId><ArticleId IdType="pmc">PMC8077944</ArticleId><ArticleId IdType="pubmed">32673563</ArticleId></ArticleIdList></Reference><Reference><Citation>Niopek D, Wehler P, Roensch J, Eils R, Di Ventura B. Optogenetic control of nuclear protein export. Nat. Commun. 2016;7:10624. doi: 10.1038/ncomms10624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms10624</ArticleId><ArticleId IdType="pmc">PMC4748110</ArticleId><ArticleId IdType="pubmed">26853913</ArticleId></ArticleIdList></Reference><Reference><Citation>Niehues S, et al. Impaired protein translation in Drosophila models for Charcot-Marie-Tooth neuropathy caused by mutant tRNA synthetases. Nat. Commun. 2015;6:7520. doi: 10.1038/ncomms8520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms8520</ArticleId><ArticleId IdType="pmc">PMC4506996</ArticleId><ArticleId IdType="pubmed">26138142</ArticleId></ArticleIdList></Reference><Reference><Citation>Casci I, Pandey UB. A fruitful endeavor: modeling ALS in the fruit fly. Brain Res. 2015;1607:47&#x2013;74. doi: 10.1016/j.brainres.2014.09.064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2014.09.064</ArticleId><ArticleId IdType="pmc">PMC4385417</ArticleId><ArticleId IdType="pubmed">25289585</ArticleId></ArticleIdList></Reference><Reference><Citation>Klim JR, et al. ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. Nat. Neurosci. 2019;22:167&#x2013;179. doi: 10.1038/s41593-018-0300-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0300-4</ArticleId><ArticleId IdType="pmc">PMC7153761</ArticleId><ArticleId IdType="pubmed">30643292</ArticleId></ArticleIdList></Reference><Reference><Citation>Melamed Z, et al. Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nat. Neurosci. 2019;22:180&#x2013;190. doi: 10.1038/s41593-018-0293-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0293-z</ArticleId><ArticleId IdType="pmc">PMC6348009</ArticleId><ArticleId IdType="pubmed">30643298</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalverda B, Pickersgill H, Shloma VV, Fornerod M. Nucleoporins directly stimulate expression of developmental and cell-cycle genes inside the nucleoplasm. Cell. 2010;140:360&#x2013;371. doi: 10.1016/j.cell.2010.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.01.011</ArticleId><ArticleId IdType="pubmed">20144760</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackay DR, Howa AC, Werner TL, Ullman KS. Nup153 and Nup50 promote recruitment of 53BP1 to DNA repair foci by antagonizing BRCA1-dependent events. J. Cell Sci. 2017;130:3347&#x2013;3359.</Citation><ArticleIdList><ArticleId IdType="pubmed">28751496</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan L, Hanson KA, Kim SH, Tare A, Tibbetts RS. Identification of genetic modifiers of TDP-43 neurotoxicity in Drosophila. PLoS ONE. 2013;8:e57214. doi: 10.1371/journal.pone.0057214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0057214</ArticleId><ArticleId IdType="pmc">PMC3584124</ArticleId><ArticleId IdType="pubmed">23468938</ArticleId></ArticleIdList></Reference><Reference><Citation>Smitherman M, Lee K, Swanger J, Kapur R, Clurman BE. Characterization and targeted disruption of murine Nup50, a p27(Kip1)-interacting component of the nuclear pore complex. Mol. Cell Biol. 2000;20:5631&#x2013;5642. doi: 10.1128/MCB.20.15.5631-5642.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.20.15.5631-5642.2000</ArticleId><ArticleId IdType="pmc">PMC86029</ArticleId><ArticleId IdType="pubmed">10891500</ArticleId></ArticleIdList></Reference><Reference><Citation>Scekic-Zahirovic J, et al. Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss. EMBO J. 2016;35:1077&#x2013;1097. doi: 10.15252/embj.201592559.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201592559</ArticleId><ArticleId IdType="pmc">PMC4868956</ArticleId><ArticleId IdType="pubmed">26951610</ArticleId></ArticleIdList></Reference><Reference><Citation>Scekic-Zahirovic J, et al. Motor neuron intrinsic and extrinsic mechanisms contribute to the pathogenesis of FUS-associated amyotrophic lateral sclerosis. Acta Neuropathol. 2017;133:887&#x2013;906. doi: 10.1007/s00401-017-1687-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1687-9</ArticleId><ArticleId IdType="pmc">PMC5427169</ArticleId><ArticleId IdType="pubmed">28243725</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, et al. Differential screening of mutated SOD1 transgenic mice reveals early up-regulation of a fast axonal transport component in spinal cord motor neurons. Neurobiol. Dis. 2000;7:274&#x2013;285. doi: 10.1006/nbdi.2000.0292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nbdi.2000.0292</ArticleId><ArticleId IdType="pubmed">10964600</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen IE, et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer&#x2019;s disease risk. Nat. Genet. 2019;51:404&#x2013;413. doi: 10.1038/s41588-018-0311-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0311-9</ArticleId><ArticleId IdType="pmc">PMC6836675</ArticleId><ArticleId IdType="pubmed">30617256</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalls MA, et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson&#x2019;s disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 2019;18:1091&#x2013;1102. doi: 10.1016/S1474-4422(19)30320-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(19)30320-5</ArticleId><ArticleId IdType="pmc">PMC8422160</ArticleId><ArticleId IdType="pubmed">31701892</ArticleId></ArticleIdList></Reference><Reference><Citation>Hormozdiari F, et al. Leveraging molecular quantitative trait loci to understand the genetic architecture of diseases and complex traits. Nat. Genet. 2018;50:1041&#x2013;1047. doi: 10.1038/s41588-018-0148-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0148-2</ArticleId><ArticleId IdType="pmc">PMC6030458</ArticleId><ArticleId IdType="pubmed">29942083</ArticleId></ArticleIdList></Reference><Reference><Citation>Finucane HK, et al. Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types. Nat. Genet. 2018;50:621&#x2013;629. doi: 10.1038/s41588-018-0081-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0081-4</ArticleId><ArticleId IdType="pmc">PMC5896795</ArticleId><ArticleId IdType="pubmed">29632380</ArticleId></ArticleIdList></Reference><Reference><Citation>International HapMap, C. The International HapMap Project. Nature. 2003;426:789&#x2013;796. doi: 10.1038/nature02168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature02168</ArticleId><ArticleId IdType="pubmed">14685227</ArticleId></ArticleIdList></Reference><Reference><Citation>Finucane HK, et al. Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat. Genet. 2015;47:1228&#x2013;1235. doi: 10.1038/ng.3404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3404</ArticleId><ArticleId IdType="pmc">PMC4626285</ArticleId><ArticleId IdType="pubmed">26414678</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Lee SH, Goddard ME, Visscher PM. GCTA: a tool for genome-wide complex trait analysis. Am. J. Hum. Genet. 2011;88:76&#x2013;82. doi: 10.1016/j.ajhg.2010.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2010.11.011</ArticleId><ArticleId IdType="pmc">PMC3014363</ArticleId><ArticleId IdType="pubmed">21167468</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Spek RAA, et al. The project MinE databrowser: bringing large-scale whole-genome sequencing in ALS to researchers and the public. Amyotroph. Lateral Scler. Frontotemporal Degener. 2019;20:432&#x2013;440. doi: 10.1080/21678421.2019.1606244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1606244</ArticleId><ArticleId IdType="pmc">PMC7893599</ArticleId><ArticleId IdType="pubmed">31280677</ArticleId></ArticleIdList></Reference><Reference><Citation>Genovese G, et al. Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia. Nat. Neurosci. 2016;19:1433&#x2013;1441. doi: 10.1038/nn.4402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4402</ArticleId><ArticleId IdType="pmc">PMC5104192</ArticleId><ArticleId IdType="pubmed">27694994</ArticleId></ArticleIdList></Reference><Reference><Citation>Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 2010;26:2190&#x2013;2191. doi: 10.1093/bioinformatics/btq340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btq340</ArticleId><ArticleId IdType="pmc">PMC2922887</ArticleId><ArticleId IdType="pubmed">20616382</ArticleId></ArticleIdList></Reference><Reference><Citation>Japtok J, et al. Stepwise acquirement of hallmark neuropathology in FUS-ALS iPSC models depends on mutation type and neuronal aging. Neurobiol. Dis. 2015;82:420&#x2013;429. doi: 10.1016/j.nbd.2015.07.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2015.07.017</ArticleId><ArticleId IdType="pubmed">26253605</ArticleId></ArticleIdList></Reference><Reference><Citation>Catanese A, et al. Retinoic acid worsens ATG10-dependent autophagy impairment in TBK1-mutant hiPSC-derived motoneurons through SQSTM1/p62 accumulation. Autophagy. 2019;15:1719&#x2013;1737. doi: 10.1080/15548627.2019.1589257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2019.1589257</ArticleId><ArticleId IdType="pmc">PMC6735587</ArticleId><ArticleId IdType="pubmed">30939964</ArticleId></ArticleIdList></Reference><Reference><Citation>Vandesompele, J. et al. Accurate normalization of real-time quantitative RT- PCR data by geometric averaging of multiple internal control genes. Genome Biol.3, research0034.1 (2002).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC126239</ArticleId><ArticleId IdType="pubmed">12184808</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>